Novel oral anticoagulants. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy1

Diseases26

Venous Thromboembolism Thromboembolism Hemorrhage Thrombophlebitis Atrial Fibrillation Thrombosis Venous Thrombosis Pulmonary Embolism Thrombophilia Blood Coagulation Disorders Stroke Hematoma Postoperative Hemorrhage Embolism Cerebral Hemorrhage Recurrence Intracranial Hemorrhages Antiphospholipid Syndrome Heart Diseases Heart Valve Diseases Postoperative Complications Graft Occlusion, Vascular Activated Protein C Resistance Acute Coronary Syndrome Brain Ischemia Protein C Deficiency

Chemicals and Drugs54

Anticoagulants beta-Alanine Pyridones Thiophenes Benzimidazoles Acenocoumarol Warfarin Phenindione Phenprocoumon Vitamin K Antithrombins Factor Xa Lupus Coagulation Inhibitor Heparin, Low-Molecular-Weight Heparin Prothrombin Protein C Blood Coagulation Factors Morpholines Vitamin K Epoxide Reductases Aspirin Platelet Aggregation Inhibitors Coumarins Fibrinolytic Agents Rodenticides Dicumarol Factor X Thrombin Thromboplastin 4-Hydroxycoumarins Enoxaparin Coagulants Pyrazoles Protein S Azetidines Thrombomodulin Factor VII Amidines Fibrin Fibrinogen Degradation Products Antithrombin III Antibodies, Antiphospholipid Antibodies, Anticardiolipin Heparin Antagonists Mixed Function Oxygenases Pyridines Hirudins Factor V beta 2-Glycoprotein I Factor Va Pipecolic Acids Ticlopidine Aryl Hydrocarbon Hydroxylases Dermatan Sulfate Heparin Cofactor II

Analytical, Diagnostic and Therapeutic Techniques and Equipment26

Administration, Oral International Normalized Ratio Prothrombin Time Blood Coagulation Tests Partial Thromboplastin Time Drug Monitoring Oral Surgical Procedures Treatment Outcome Thrombin Time Heart Valve Prosthesis Perioperative Care Pharmacovigilance Randomized Controlled Trials as Topic Drug Substitution Risk Factors Clinical Trials as Topic Prospective Studies Follow-Up Studies Clinical Trials, Phase III as Topic Drug Therapy, Combination Drug Administration Schedule Thrombolytic Therapy Risk Assessment Retrospective Studies Injections, Subcutaneous Incidence

Psychiatry and Psychology1

Medication Adherence

Phenomena and Processes8

Prothrombin Time Blood Coagulation Partial Thromboplastin Time Thrombin Time Hemostasis Time Factors Drug Interactions Dose-Response Relationship, Drug

Disciplines and Occupations1

Pharmacogenetics

Information Science2

Pharmacovigilance Incidence

Named Groups1

Health Care19

Treatment Outcome Perioperative Care Pharmacovigilance Randomized Controlled Trials as Topic Drug Substitution Risk Factors Clinical Trials as Topic Prospective Studies Follow-Up Studies Clinical Trials, Phase III as Topic Point-of-Care Systems Risk Assessment Retrospective Studies Practice Guidelines as Topic Rodent Control Medication Adherence Drug Utilization Guideline Adherence Incidence

Anatomy Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Information Science Named Groups Health Care

Anticoagulants beta-Alanine Pyridones Administration, Oral Thiophenes Venous Thromboembolism Benzimidazoles Acenocoumarol Warfarin International Normalized Ratio Prothrombin Time Phenindione Thromboembolism Hemorrhage Phenprocoumon Vitamin K Thrombophlebitis Antithrombins Factor Xa Blood Coagulation Blood Coagulation Tests Atrial Fibrillation Lupus Coagulation Inhibitor Heparin, Low-Molecular-Weight Heparin Prothrombin Partial Thromboplastin Time Drug Monitoring Thrombosis Venous Thrombosis Protein C Blood Coagulation Factors Morpholines Pulmonary Embolism Vitamin K Epoxide Reductases Aspirin Platelet Aggregation Inhibitors Coumarins Fibrinolytic Agents Thrombophilia Blood Coagulation Disorders Rodenticides Stroke Dicumarol Factor X Thrombin Thromboplastin 4-Hydroxycoumarins Hematoma Enoxaparin Oral Surgical Procedures Postoperative Hemorrhage Coagulants Treatment Outcome Thrombin Time Pyrazoles Embolism Heart Valve Prosthesis Protein S Perioperative Care Cerebral Hemorrhage Azetidines Pharmacovigilance Hemostasis Thrombomodulin Randomized Controlled Trials as Topic Drug Substitution Recurrence Intracranial Hemorrhages Factor VII Time Factors Amidines Risk Factors Drug Interactions Fibrin Fibrinogen Degradation Products Antiphospholipid Syndrome Pharmacogenetics Clinical Trials as Topic Prospective Studies Follow-Up Studies Antithrombin III Clinical Trials, Phase III as Topic Antibodies, Antiphospholipid Plasma Point-of-Care Systems Drug Therapy, Combination Drug Administration Schedule Antibodies, Anticardiolipin Dose-Response Relationship, Drug Heart Diseases Thrombolytic Therapy Heart Valve Diseases Risk Assessment Retrospective Studies Injections, Subcutaneous Heparin Antagonists Postoperative Complications Mixed Function Oxygenases Graft Occlusion, Vascular Pyridines

No FAQ available that match "novel oral anticoagulants"